Given the critical role of human CES1 (hCES1) in metabolizing cholesteryl esters, inhibitors of hCES1 have the potential to treat hypertriglyceridemia, obesity, type 2 diabetes and atherosclerosis [80,81,82,83]. The gene discussed is CES1; the disease is obesity disorder.